Total de visites
Visites | |
---|---|
Intracranial ... | 64 |
Total de visites per mes
d’octubre 2023 | de novembre 2023 | de desembre 2023 | de gener 2024 | de febrer 2024 | de març 2024 | d’abril 2024 | |
---|---|---|---|---|---|---|---|
Intracranial ... | 0 | 0 | 0 | 1 | 1 | 3 | 2 |
Total de descàrregues del fitxer
Visites | |
---|---|
intracranial_and_extracranial_efficacy_lorlatinib_patients_alk_positive_non_small_cell_lung_cancer_previously_treated_second_generation_alk_tkis_2021.pdf | 24 |
intracranial_and_extracranial_efficacy_lorlatinib_patients_alk_positive_non_small_cell_lung_cancer_previously_treated_second_generation_alk_tkis_2021_taula5.pdf | 14 |
intracranial_and_extracranial_efficacy_lorlatinib_patients_alk_positive_non_small_cell_lung_cancer_previously_treated_second_generation_alk_tkis_2021_taula2.pdf | 13 |
intracranial_and_extracranial_efficacy_lorlatinib_patients_alk_positive_non_small_cell_lung_cancer_previously_treated_second_generation_alk_tkis_2021_taula3.pdf | 13 |
intracranial_and_extracranial_efficacy_lorlatinib_patients_alk_positive_non_small_cell_lung_cancer_previously_treated_second_generation_alk_tkis_2021_taula1.pdf | 12 |
intracranial_and_extracranial_efficacy_lorlatinib_patients_alk_positive_non_small_cell_lung_cancer_previously_treated_second_generation_alk_tkis_2021_figura1.pdf | 11 |
intracranial_and_extracranial_efficacy_lorlatinib_patients_alk_positive_non_small_cell_lung_cancer_previously_treated_second_generation_alk_tkis_2021_taula4.pdf | 9 |
Visites per país
Visites | |
---|---|
Estats Units | 40 |
Espanya | 10 |
Canadà | 6 |
Alemanya | 2 |
Regne Unit | 2 |
Bèlgica | 1 |
Xipre | 1 |
Finlàndia | 1 |
França | 1 |
Visites per ciutat
Visites | |
---|---|
Chandler | 11 |
Barcelona | 7 |
Ashburn | 5 |
Chicago | 5 |
Québec | 3 |
Beauharnois | 2 |
London | 2 |
Boardman | 1 |
Brussels | 1 |
Des Moines | 1 |